Testing inhaled tobramycin for very preterm infants with lung disease
Official title: Phase 1 trial of inhaled tobramycin in very preterm infants with bronchopulmonary dysplasia
Funded at Children's Hosp of Philadelphia · NIH-10688294 · Data updated 2026-11-12
This study is looking at how inhaled tobramycin, an antibiotic, can help very preterm babies with bronchopulmonary dysplasia (BPD) by delivering the medicine straight to their lungs to fight harmful bacteria and improve their breathing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | August 20, 2021 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $308,000 |
| NIH project number | 5R34HL155690-03 |
| Project ID | NIH-10688294 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are very preterm infants diagnosed with bronchopulmonary dysplasia.
✕Less likely to help
Patients who are not very preterm infants or do not have bronchopulmonary dysplasia may not benefit from this research.
What this research studies
This research investigates the use of inhaled tobramycin, an antibiotic, to treat very preterm infants suffering from bronchopulmonary dysplasia (BPD), a serious lung condition. The study aims to deliver the medication directly to the lungs, where it can effectively target harmful bacteria that worsen respiratory health. By focusing on this method, the research seeks to improve outcomes for infants who currently have limited treatment options. The trial will assess the safety and effectiveness of this approach in a vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to improved respiratory health and quality of life for very preterm infants with bronchopulmonary dysplasia.
How similar studies have gone: Previous research has shown promising results with inhaled antibiotics in similar conditions, suggesting potential for success in this trial.
Where this research is happening
-
Children's Hosp of Philadelphia
Philadelphia, United States Active
Researchers
- Principal investigator: Downes, Kevin James — Children's Hosp of Philadelphia
- Study coordinator: Downes, Kevin James
Related research
Other NIH-funded projects on the same topics.
-
L-Citrulline for BPD-related Pulmonary Hypertension in Preterm Babies
A first-in-human study will test safe and effective doses of L-citrulline given by mouth to stability-preterm infants at risk for lung blood pressure problems.
-
Comparing two feeding methods for very preterm infants with lung disease
This study is looking at whether feeding very premature babies through a different route (transpyloric feeding) instead of the usual method (gastric feeding) can help improve their health and reduce problems like reflux, especially for those with a serious lung condition called bronchopulmonary dysplasia (BPD).
-
Screening and treatment of Chlamydia infection in pregnancy to help prevent preterm birth
This grant studies whether screening pregnant people for Chlamydia trachomatis and treating those who are positive can reduce the risk of preterm birth.
-
Preterm infant body composition and early-life health after NICU stay
This grant studies how body composition in very preterm babies relates to later brain development and risk of obesity or diabetes, with findings meant to improve care from NICU through early childhood.
-
Brain injury risk in preterm babies with heart disease and how surgery choices affect their brains
This project follows newborns with congenital heart disease born early to understand how their brains are affected and how different surgical approaches might influence outcomes.
-
Xylitol to Prevent Periodontal Disease and Preterm Birth in Pregnancy and Early Childhood
A safe, inexpensive chewable gum approach using xylitol is tested to help pregnant people reduce gum disease and lower the chance of preterm birth and related child health problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.